drugset / Trial / NCT00651443
Mechanism of Action of Galiximab in Subjects With Previously Untreated Follicular Non-Hodgkin's Lymphoma
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the mechanism(s) of action of galiximab in subjects with previously untreated follicular NHL.
Timeline
- Start
- 2008-08
- Primary completion
- 2010-11
- Completion
- 2010-12
Outcome
Outcome not reported
Stopped (Business): “A company's strategic decision to focus on areas whereit believes it can be competitive and decided to exit Oncology”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | galiximab | Monoclonal antibody | 500 mg/m2 | Intravenous |